Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Integrated Core Strategies (US) LLC reported a 5.80% stake in Lexeo Therapeutics, Inc. (Schedule 13G)

Event Apr 22, 2025 · Filed Apr 28, 2025

Integrated Core Strategies (US) LLC reported a 5.80% stake in Lexeo Therapeutics, Inc., 1,933,379 shares, as a passive investor on Apr 22, 2025. Filed Apr 28, 2025 (Schedule 13G).

Stake
5.80%
Shares
1,933,379
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC5.80%1,933,379
Millennium Management LLC5.80%1,933,379
Millennium Group Management LLC5.80%1,933,379
Israel A. Englander5.80%1,933,379

Source

View original at SEC

Related